Skip to main content
GutCited

Saccharomyces boulardii для Clostridioides difficile Infection (CDI)

B

Meta-analyses show S. boulardii reduces CDI recurrence by 50-60% when given as adjunct to standard antibiotic treatment. Strongest evidence for preventing recurrent CDI.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dsaccharomyces\u002Dboulardii\u0026condition\u003Dclostridioides\u002Ddifficile'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Итог

Meta-analyses show S. boulardii reduces CDI recurrence by 50-60% when given as adjunct to standard antibiotic treatment. Strongest evidence for preventing recurrent CDI.

Key Study Findings

Review
The evidence for probiotics in the treatment of digestive disorders in the pediatric population.
Dose: None или: None Outcome: None Эффект: None None

Популяция: Pediatric population

Review
Clostridioides difficile Infections: Prevention and Treatment Strategies.
Dose: None или: None Outcome: C. difficile infection treatment outcomes Эффект: None None

Популяция: Patients with C. difficile infection

Review 520 weeks
Qualitative Analysis of the Efficacy of Probiotic Strains in the Prevention of Antibiotic-Associated Diarrhea.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

Review
Clostridium difficile Colitis Prevention and Treatment.
Dose: None или: None Outcome: Diarrhea outcomes Эффект: None None

Популяция: None

Systematic Review n=228
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Dose: None или: None Outcome: Diarrhea outcomes Эффект: None None

Популяция: None

Review
Probiotics in Gastroenterology: How Pro Is the Evidence in Adults?
Dose: None или: None Outcome: GI condition outcomes (C. diff, AAD, H. pylori) Эффект: None None

Популяция: Adults with GI conditions

Key Statistics

6

Исследования

3000

Участники

Positive

B

Оценка

Referenced Papers

Journal of gastroenterology … 2025 10 цитирований
Advances in experimental … 2024 2 цитирований
Advances in experimental … 2019 17 цитирований
The American journal … 2018 46 цитирований
Journal of pediatric … 2016 233 цитирований
Clinical and experimental … 2016 82 цитирований
Journal of clinical … 2011 432 цитирований
American journal of … 2010
Current opinion in … 2009 82 цитирований
The American journal … 2001 648 цитирований
International journal of … 2000 181 цитирований
Clinical infectious diseases … 1998 346 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
250-500 mg/day (equivalent to 5-10 billion CFU)
aadprevention:
500 mg/day (start with antibiotic, continue 7 days after)
cdiffprevention:
500 mg twice daily as adjunct to standard therapy
travelersdiarrhea:
250-500 mg/day starting 5 days before travel

Верхний предел: Well-tolerated up to 1,000 mg/day in clinical trials

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Mixed --
None -- Positive --
None 520 weeks Positive --
None -- Mixed --
None -- Mixed 228
None -- Mixed --
None -- Mixed --
None -- Mixed --

Лучшее время приёма: Can be taken with or without food; space 2 hours from antifungals

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Mild gas and bloating
  • Rare: fungemia in critically ill patients with central venous catheters
  • Thirst (yeast may increase water requirements)
  • Very rare: potential environmental contamination risk in ICU settings

Известные взаимодействия

  • Antifungal medications (may kill S. boulardii, reducing effectiveness)
  • Monoamine oxidase inhibitors (S. boulardii contains tyramine)
  • Immunosuppressants (theoretical risk of fungemia in immunocompromised patients)

Допустимый верхний уровень потребления: Well-tolerated up to 1,000 mg/day in clinical trials

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Saccharomyces boulardii help with Clostridioides difficile Infection (CDI)?
Based on 6 studies with 3,000 participants, there is moderate evidence from clinical studies that Saccharomyces boulardii may support Clostridioides difficile Infection (CDI) management. Our evidence grade is B (Good Evidence).
How much Saccharomyces boulardii should I take for Clostridioides difficile Infection (CDI)?
Studies have used various dosages. A commonly studied range is 250-500 mg/day (equivalent to 5-10 billion CFU). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Saccharomyces boulardii?
Reported side effects may include Mild gas and bloating, Rare: fungemia in critically ill patients with central venous catheters, Thirst (yeast may increase water requirements), Very rare: potential environmental contamination risk in ICU settings. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Saccharomyces boulardii and Clostridioides difficile Infection (CDI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

Related Evidence

Saccharomyces boulardii для других состояний

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.